OBJECTIVE: To compare the efficacy of in situ transforming growth factor-beta1 (TGF-beta1)-pretreated periosteum to untreated periosteum for regeneration of osteochondral tissue in rabbits. METHODS: In the pretreatment group, 12 month-old New Zealand white rabbits received subperiosteal injections of 200 ng of TGF-beta1 percutaneously in the medial side of the proximal tibia, 7 days prior to surgery. Control rabbits received no treatment prior surgery. Osteochondral transverse defects measuring 5mm proximal to distal and spanning the entire width of the patellar groove were created and repaired with untreated or TGF-beta1-pretreated periosteal grafts. Post-operatively the rabbits resumed normal cage activity for 6 weeks. RESULTS: Complete filling of the defects with regenerated tissue was observed in both the TGF-beta1-pretreated and control groups with reformation of the original contours of the patellar groove. The total histological score (modified O'Driscoll) in the TGF-beta1-pretreated group, 20 (95% Confidence Interval (CI), 19-21), was significantly higher (P=0.0001) than the control group, 18 (16-19). The most notable improvements were in structural integrity and subchondral bone regeneration. No significant differences in glycosaminoglycan or type II collagen content, or equilibrium modulus were found between the surgical groups. The cambium of the periosteum regenerated at the graft harvest site was significantly thicker (P=0.0065) in the TGF-beta1-pretreated rabbits, 121 microm (94-149), compared to controls, 74 microm (52-96), after 6 weeks. CONCLUSIONS: This study demonstrates that in situ pretreatment of periosteum with TGF-beta1 improves osteochondral tissue regeneration at 6-weeks post-op compared to untreated periosteum in 12 month-old rabbits. Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
OBJECTIVE: To compare the efficacy of in situ transforming growth factor-beta1 (TGF-beta1)-pretreated periosteum to untreated periosteum for regeneration of osteochondral tissue in rabbits. METHODS: In the pretreatment group, 12 month-old New Zealand white rabbits received subperiosteal injections of 200 ng of TGF-beta1 percutaneously in the medial side of the proximal tibia, 7 days prior to surgery. Control rabbits received no treatment prior surgery. Osteochondral transverse defects measuring 5mm proximal to distal and spanning the entire width of the patellar groove were created and repaired with untreated or TGF-beta1-pretreated periosteal grafts. Post-operatively the rabbits resumed normal cage activity for 6 weeks. RESULTS: Complete filling of the defects with regenerated tissue was observed in both the TGF-beta1-pretreated and control groups with reformation of the original contours of the patellar groove. The total histological score (modified O'Driscoll) in the TGF-beta1-pretreated group, 20 (95% Confidence Interval (CI), 19-21), was significantly higher (P=0.0001) than the control group, 18 (16-19). The most notable improvements were in structural integrity and subchondral bone regeneration. No significant differences in glycosaminoglycan or type II collagen content, or equilibrium modulus were found between the surgical groups. The cambium of the periosteum regenerated at the graft harvest site was significantly thicker (P=0.0065) in the TGF-beta1-pretreated rabbits, 121 microm (94-149), compared to controls, 74 microm (52-96), after 6 weeks. CONCLUSIONS: This study demonstrates that in situ pretreatment of periosteum with TGF-beta1 improves osteochondral tissue regeneration at 6-weeks post-op compared to untreated periosteum in 12 month-old rabbits. Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Authors: Hiroshi Mizuta; Arunik Sanyal; Takumi Fukumoto; James S Fitzsimmons; Nobuzo Matsui; Mark E Bolander; Merry Jo Oursler; Shawn W O'Driscoll Journal: J Orthop Res Date: 2002-05 Impact factor: 3.494
Authors: Laura C Ortinau; Hamilton Wang; Kevin Lei; Lorenzo Deveza; Youngjae Jeong; Yannis Hara; Ingo Grafe; Scott B Rosenfeld; Dongjun Lee; Brendan Lee; David T Scadden; Dongsu Park Journal: Cell Stem Cell Date: 2019-12-05 Impact factor: 24.633
Authors: Chen-Shuang Li; Xinli Zhang; Bruno Péault; Jie Jiang; Kang Ting; Chia Soo; Yan-Heng Zhou Journal: Tissue Eng Part A Date: 2016-01-27 Impact factor: 3.845
Authors: Katja Ahtiainen; Jari Mauno; Ville Ellä; Jaana Hagström; Christian Lindqvist; Susanna Miettinen; Timo Ylikomi; Minna Kellomäki; Riitta Seppänen Journal: J R Soc Interface Date: 2013-05-29 Impact factor: 4.118